| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...863527G |
| P356 | DOI | 10.1371/JOURNAL.PONE.0063527 |
| P932 | PMC publication ID | 3646759 |
| P698 | PubMed publication ID | 23667632 |
| P5875 | ResearchGate publication ID | 236693398 |
| P50 | author | Michael Weller | Q2779469 |
| Katrin Anne Becker | Q66360854 | ||
| Ghazaleh Tabatabai | Q45324636 | ||
| Erich Gulbins | Q37611826 | ||
| P2093 | author name string | Caroline Happold | |
| Caroline Herrmann | |||
| Dorothee Gramatzki | |||
| P2860 | cites work | Host acid sphingomyelinase regulates microvascular function not tumor immunity. | Q53879620 |
| Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases. | Q54605576 | ||
| Bag-1 and Bcl-2 gene transfer in malignant glioma: modulation of cell cycle regulation and apoptosis. | Q55475811 | ||
| Ceramide glycosylation potentiates cellular multidrug resistance | Q57373871 | ||
| TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown | Q67505708 | ||
| Inhibitors of glucosylceramide synthase | Q73186765 | ||
| Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency | Q73430532 | ||
| Involvement of Fas receptor and not tumor necrosis factor-alpha receptor in ultraviolet-induced activation of acid sphingomyelinase | Q73631583 | ||
| Comparative investigation of sphingoid bases and fatty acids in ceramides and sphingomyelins from human ovarian malignant tumors and normal ovary | Q77486730 | ||
| Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma. | Q42882364 | ||
| Monitoring of cell viability and cell growth in a hollow-fiber bioreactor by use of the dye Alamar Blue | Q43596502 | ||
| C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis | Q43728188 | ||
| The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs | Q44401173 | ||
| Chemotherapy-induced cell death in primary cerebellar granule neurons but not in astrocytes: in vitro paradigm of differential neurotoxicity | Q45166126 | ||
| High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter | Q45732758 | ||
| FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway | Q46885906 | ||
| Glioma tropism of lentivirally transduced hematopoietic progenitor cells. | Q48220159 | ||
| Synergistic antiglioma activity of radiotherapy and enzastaurin | Q48315412 | ||
| Ceramide levels are inversely associated with malignant progression of human glial tumors. | Q48552560 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
| A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| p53-Independent ceramide formation in human glioma cells during gamma-radiation-induced apoptosis | Q28256905 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer | Q32061450 | ||
| Targeting ceramide metabolism--a strategy for overcoming drug resistance | Q32133855 | ||
| Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034. | Q33407127 | ||
| Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinoma | Q33683147 | ||
| Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens | Q33914230 | ||
| A compendium of gene expression in normal human tissues | Q34107680 | ||
| Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis | Q34994393 | ||
| Ceramide and cell death receptor clustering | Q35047148 | ||
| Biologically active sphingolipids in cancer pathogenesis and treatment | Q35852313 | ||
| Standards of care for treatment of recurrent glioblastoma--are we there yet? | Q36500401 | ||
| Biological aspects of ceramide-enriched membrane domains | Q36816324 | ||
| The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases | Q36879383 | ||
| Rembrandt: helping personalized medicine become a reality through integrative translational research | Q37103992 | ||
| Current concepts and management of glioblastoma | Q37904921 | ||
| Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells | Q39352627 | ||
| Glucosylceramide synthase protects glioblastoma cells against autophagic and apoptotic death induced by temozolomide and Paclitaxel. | Q39413826 | ||
| Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines | Q39511962 | ||
| Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism | Q39553593 | ||
| Conditional probability of long-term survival in glioblastoma: a population-based analysis | Q39619773 | ||
| Ceramide metabolism determines glioma cell resistance to chemotherapy | Q39807508 | ||
| Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells | Q40091503 | ||
| Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy | Q40118291 | ||
| Apoptosis of human breast carcinoma cells in the presence of cis-platin and L-/D-PPMP: IV. Modulation of replication complexes and glycolipid: Glycosyltransferases | Q40280745 | ||
| O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells | Q40331848 | ||
| Lack of ceramide generation and altered sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells | Q40339862 | ||
| The search for synergy: a critical review from a response surface perspective. | Q40417895 | ||
| Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide. | Q40485952 | ||
| Apoptosis of human carcinoma cells in the presence of potential anti-cancer drugs: III. Treatment of Colo-205 and SKBR3 cells with: cis -platin, Tamoxifen, Melphalan, Betulinic acid, L-PDMP, L-PPMP, and GD3 ganglioside | Q40509743 | ||
| Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. | Q40554384 | ||
| Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. | Q40556362 | ||
| Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. | Q40906953 | ||
| Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells | Q40984564 | ||
| Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. | Q41440948 | ||
| Occurrence of two molecular forms of human acid sphingomyelinase | Q41450142 | ||
| Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. | Q42555356 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ceramides | Q424213 |
| cell death | Q2383867 | ||
| chemotherapy | Q974135 | ||
| P304 | page(s) | e63527 | |
| P577 | publication date | 2013-05-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway | |
| P478 | volume | 8 |
| Q35830894 | Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival |
| Q37295253 | Essential role for acid sphingomyelinase-inhibited autophagy in melanoma response to cisplatin |
| Q27335346 | GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor-associated epilepsy. |
| Q38195691 | Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance |
| Q95270504 | Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment |
| Q92446113 | Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma |
Search more.